<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Clin Cases</journal-id><journal-id journal-id-type="publisher-id">WJCC</journal-id><journal-title-group><journal-title>World Journal of Clinical Cases</journal-title></journal-title-group><issn pub-type="epub">2307-8960</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5480068</article-id><article-id pub-id-type="other">jWJCC.v5.i6.pg203</article-id><article-id pub-id-type="doi">10.12998/wjcc.v5.i6.203</article-id><article-categories><subj-group subj-group-type="heading"><subject>Minireviews</subject></subj-group></article-categories><title-group><article-title>Clinical variants of pityriasis rosea</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Urbina</surname><given-names>Francisco</given-names></name></contrib><contrib contrib-type="author"><name><surname>Das</surname><given-names>Anupam</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sudy</surname><given-names>Emilio</given-names></name></contrib><aff>Francisco Urbina, Emilio Sudy, Dermatologists in Private Practice, Santiago de Chile 6760964, Chile</aff><aff>Anupam Das, Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal 700032, India</aff></contrib-group><author-notes><fn><p>Author contributions: All the authors have contributed to the preparation of the manuscript and collection of pictures.</p><p>Correspondence to: Francisco Urbina, MD, Dermatologist in Private Practice, Algeciras 583, Las Condes, Santiago de Chile 6760964, Chile. <email>fcourbina@hotmail.com</email></p><p>Telephone: +56-22-2285427</p></fn></author-notes><pub-date pub-type="ppub"><day>16</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>16</day><month>6</month><year>2017</year></pub-date><volume>5</volume><issue>6</issue><fpage>203</fpage><lpage>211</lpage><history><date date-type="received"><day>28</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>21</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>18</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9;The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><abstract><p>Pityriasis rosea (PR) is a common erythemato-squamous dermatosis which almost always, is easily diagnosed. Mostly the disease presents in its classical form. However, clinical dermatology is all about variations and PR is not an exception. Variants of the disease in some cases may be troublesome to diagnose and confuse clinicians. Prompt diagnosis and treatment of the condition becomes necessary to avoid unnecessary investigations. We hereby review and illustrate atypical presentations of the disease, including diverse forms of location and morphology of the lesions, the course of the eruption, and its differential diagnoses.</p></abstract><kwd-group><kwd>Pityriasis</kwd><kwd>Pityriasis rosea</kwd><kwd>Pityriasis rosea of Gibert</kwd><kwd>Herald patch</kwd><kwd>Papulo-squamous dermatosis</kwd></kwd-group></article-meta></front><body><p><bold>Core tip:</bold> Pityriasis rosea (PR) is a common, self-limited disease which in its typical form should not raise diagnostic doubts. Atypical forms represent 20% of cases, with diverse variants with respect to morphology and location of lesions, and evolution of the disease. Recognition of these forms may avoid unnecessary procedures. Drug ingestion may simulate PR in some cases.</p><sec><title>INTRODUCTION</title><p>Pityriasis rosea (PR) is a relatively common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years), slightly more common in females. It has a sudden onset, and in its typical presentation, the eruption is preceeded by a solitary patch termed &#x0201c;herald patch&#x0201d;, mainly located on the trunk. Few days later, a secondary eruption appears, with little pink, oval macules, with a grayish peripheral scaling collarette around them. The secondary lesions adopt a characteristic distribution along the cleavage lines of the trunk, with a configuration of a &#x0201c;Christmas tree&#x0201d;. In most cases, the eruption lasts for 6 to 8 wk. Its incidence has been estimated to be 0.68% of dermatologic patients[<xref rid="B1" ref-type="bibr">1</xref>], varying from 0.39%[<xref rid="B2" ref-type="bibr">2</xref>] to 4.8%[<xref rid="B3" ref-type="bibr">3</xref>].</p><p>Not so rarely (20%)[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>], an atypical eruption may develop, concerning several aspects about the morphology or distribution of the lesions, their symptomatology and evolution.</p><p>The purpose of this article is to review and illustrate the diverse clinical presentations of PR (Table <xref ref-type="table" rid="T1">1</xref>), which may vary in morphology, symmetry, duration, size and distribution of lesions, mucosal involvement and symptomatology.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Clinical classification of pityriasis rosea</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Classical adult PR and pediatric PR</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Based on herald patch</td></tr><tr><td align="left" rowspan="1" colspan="1">No herald patch</td></tr><tr><td align="left" rowspan="1" colspan="1">Only herald patch (absence of secondary lesions)</td></tr><tr><td align="left" rowspan="1" colspan="1">Multiple herald patches</td></tr><tr><td align="left" rowspan="1" colspan="1">Herald patch in atypical location</td></tr><tr><td align="left" rowspan="1" colspan="1">Based on location of lesions</td></tr><tr><td align="left" rowspan="1" colspan="1">Limited to scalp</td></tr><tr><td align="left" rowspan="1" colspan="1">Limited to trunk</td></tr><tr><td align="left" rowspan="1" colspan="1">Limited to limbs-girdle (pityriasis circinata et marginata of Vidal)</td></tr><tr><td align="left" rowspan="1" colspan="1">Limited to flexures (inverse type)</td></tr><tr><td align="left" rowspan="1" colspan="1">Limited to the extremities</td></tr><tr><td align="left" rowspan="1" colspan="1">Acral type</td></tr><tr><td align="left" rowspan="1" colspan="1">Along the lines of Blaschko</td></tr><tr><td align="left" rowspan="1" colspan="1">Unilateral</td></tr><tr><td align="left" rowspan="1" colspan="1">Based on morphology of lesions</td></tr><tr><td align="left" rowspan="1" colspan="1">Purpuric or hemorrhagic</td></tr><tr><td align="left" rowspan="1" colspan="1">Urticarial</td></tr><tr><td align="left" rowspan="1" colspan="1">Erythema multiforme-like</td></tr><tr><td align="left" rowspan="1" colspan="1">Papular</td></tr><tr><td align="left" rowspan="1" colspan="1">Follicular</td></tr><tr><td align="left" rowspan="1" colspan="1">Vesicular</td></tr><tr><td align="left" rowspan="1" colspan="1">Giant</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypopigmented</td></tr><tr><td align="left" rowspan="1" colspan="1">Irritated</td></tr><tr><td align="left" rowspan="1" colspan="1">Based on course of the disease</td></tr><tr><td align="left" rowspan="1" colspan="1">Relapsing</td></tr><tr><td align="left" rowspan="1" colspan="1">Recurrent</td></tr><tr><td align="left" rowspan="1" colspan="1">Persisting</td></tr><tr><td align="left" rowspan="1" colspan="1">Relapsing and persisting</td></tr><tr><td align="left" rowspan="1" colspan="1">PR-like rashes (drug-induced)</td></tr></tbody></table><table-wrap-foot><fn><p>PR: Pityriasis rosea.</p></fn></table-wrap-foot></table-wrap><sec><title>Classical PR</title><p>A classical PR is preceeded by the herald patch, an erythematous round or oval lesion, 2-5 cm in diameter, ocassionally covered by fine scales (Figure <xref ref-type="fig" rid="F1">1</xref>). Prodromal symptoms, consisting of headache, general malaise, or flu-like symptoms are ocassionally encountered. Few days later (5-15 d), a secondary rash appears, consisting of similar, but smaller lesions, mainly located on the trunk (Figure <xref ref-type="fig" rid="F2">2</xref>). Pruritus is usually mild or absent, but can vary in intensity. The eruption lasts for 4-6 wk and fades, leaving no sequelae. Generally, it only appears once throughout life. In 75% of patients the lesions appear between the ages of 10-35 years[<xref rid="B6" ref-type="bibr">6</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Herald patch. Solitary erythemato-squamous lesion, sharply defined, round or oval, mainly located on the trunk or proximal extremities.</p></caption><graphic xlink:href="WJCC-5-203-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Classical pityriasis rosea. Exanthematous eruption with erythemato-squamous lesions following cleavage lines on the trunk.</p></caption><graphic xlink:href="WJCC-5-203-g002"/></fig></sec><sec><title>Pediatric PR</title><p>Infrequently PR may affect children (Figure <xref ref-type="fig" rid="F3">3</xref>), with a prevalence between 8%[<xref rid="B7" ref-type="bibr">7</xref>] to 12%[<xref rid="B6" ref-type="bibr">6</xref>] below 10 years and 4% below 4 years of age[<xref rid="B6" ref-type="bibr">6</xref>] in Caucasians, whereas in dark-skinned children it increases to 26%[<xref rid="B8" ref-type="bibr">8</xref>]. Papular lesions prevail in them, with a short period between the herald patch and the general eruption (4 d <italic>vs</italic> 14 d in adults), and a shorter duration of the exanthema (16 d <italic>vs</italic> 45 d). The majority of cases have been described in children with ages between 3 to 9 years old, contrasting with the illustrated case of 8-mo, showing a classical variant. About half of the cases show prodromal symptoms[<xref rid="B7" ref-type="bibr">7</xref>].</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Pediatric pityriasis rosea. Typical lesions of PR affecting an 8-mo-old boy. PR: Pityriasis rosea.</p></caption><graphic xlink:href="WJCC-5-203-g003"/></fig></sec></sec><sec><title>BRIEF DESCRIPTION OF CLINICAL VARIANTS OF PR</title><sec><title>Herald patch in atypical location</title><p>Although not mentioned in the literature, we had the opportunity to come across a patient who presented with a herald patch on a sole, and a secondary classical eruption on the trunk and proximal aspect of the extremities (Figure <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Herald patch in atypical location. Herald patch on a sole (A) and (B) typical PR eruption affecting trunk and proximal thighs. PR: Pityriasis rosea.</p></caption><graphic xlink:href="WJCC-5-203-g004"/></fig></sec><sec><title>Circinata and marginata PR</title><p>Seen mainly in adults with few and large lesions only located on limbs-girdle, hips, shoulders, axillae or inguinal regions[<xref rid="B9" ref-type="bibr">9</xref>-<xref rid="B11" ref-type="bibr">11</xref>].</p></sec><sec><title>Inversus PR</title><p>The lesions are located on flexural areas (axillae, groins), face, neck (Figure <xref ref-type="fig" rid="F5">5</xref>), and acral areas (palms and soles), without affecting the trunk[<xref rid="B12" ref-type="bibr">12</xref>].</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Inversus pityriasis rosea. Lesions distributed on face and neck in two patients; the trunk is not affected.</p></caption><graphic xlink:href="WJCC-5-203-g005"/></fig></sec><sec><title>PR of extremities</title><p>In this variant, the lesions are confined to the extremities, with typical squamous plaques (Figure <xref ref-type="fig" rid="F6">6</xref>). The trunk is not affected.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p>Pityriasis rosea of the extremities. Lesions affecting only the extremities in two different cases, without trunk involvement.</p></caption><graphic xlink:href="WJCC-5-203-g006"/></fig></sec><sec><title>Acral PR</title><p>The lesions are exclusively located on palms, wrists, soles[<xref rid="B13" ref-type="bibr">13</xref>] (Figure <xref ref-type="fig" rid="F7">7</xref>), without involvement of the flexures (axillae, groins and face), opposite to inversus PR.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p>Acral pityriasis rosea. Desquamation affecting the palms.</p></caption><graphic xlink:href="WJCC-5-203-g007"/></fig></sec><sec><title>Purpuric or hemorrhagic PR</title><p>Macular purpuric lesions and petechiae may appear over different locations (Figure <xref ref-type="fig" rid="F8">8</xref>) including the palate. Purpuric lesions have also appeared bilaterally on the legs in a man with a typical rash on the trunk, affecting the lines of cleavage and with collarette scaling[<xref rid="B4" ref-type="bibr">4</xref>].</p><fig id="F8" position="float"><label>Figure 8</label><caption><p>Purpuric pityriasis rosea. Round and oval purpuric lesions affecting the neck of a young woman.</p></caption><graphic xlink:href="WJCC-5-203-g008"/></fig></sec><sec><title>Urticarial PR</title><p>Palpable itchy wheals-like lesions with peripheral collarette scaling (Figure <xref ref-type="fig" rid="F9">9</xref>) following the lines of skin cleavage[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B10" ref-type="bibr">10</xref>].</p><fig id="F9" position="float"><label>Figure 9</label><caption><p>Urticarial pityriasis rosea. Palpable edematous, erythematous lesions with collarette scaling.</p></caption><graphic xlink:href="WJCC-5-203-g009"/></fig></sec><sec><title>Erythema multiforme-like PR</title><p>In some cases, classical lesions of PR may be accompanied by targetoid lesions resembling erythema multiforme (Figure <xref ref-type="fig" rid="F10">10</xref>). It presents with papulosquamous lesions, admixed with few targetoid lesions distributed on the trunk, face, neck or arms[<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>]. There is no history of herpes simplex infection.</p><fig id="F10" position="float"><label>Figure 10</label><caption><p>Erythema multiforme-like pityriasis rosea. Annular and papular lesions resembling erythema multiforme.</p></caption><graphic xlink:href="WJCC-5-203-g010"/></fig></sec><sec><title>Papular PR</title><p>Multiple small papular lesions, 1-3 mm in diameter with peripheral collarette, located on the trunk and proximal extremities, along the skin cleavage lines (Figure <xref ref-type="fig" rid="F11">11</xref>). It appears predominantly in young patients[<xref rid="B4" ref-type="bibr">4</xref>].</p><fig id="F11" position="float"><label>Figure 11</label><caption><p>Papular pityriasis rosea. A: Papular lesions with peripheral collarette (Courtesy of Priyankar Misra, Junior Resident, Dermatology, Burdwan Medical College, West Bengal, India); B: Herald patch on the neck and disseminated discrete papular eruption in a girl.</p></caption><graphic xlink:href="WJCC-5-203-g011"/></fig></sec><sec><title>Follicular PR</title><p>It has been described in a 9-year-old boy with predominantly follicular scaly lesions, arranged in annular configuration[<xref rid="B16" ref-type="bibr">16</xref>]. The initial lesions consisted of pruritic plaques mainly located on the abdomen, thighs and groins; five days later, a striking follicular eruption - with central clearing and a peripheral collarette- developed on the posterior trunk. Prodromal symptoms included sore throat, malaise and low grade fever (Figure <xref ref-type="fig" rid="F12">12</xref>).</p><fig id="F12" position="float"><label>Figure 12</label><caption><p>Follicular pityriasis rosea. Follicular lesions with scaling (Courtesy of Shankila Mittal, Junior Resident, Dermatology, Maulana Azad Medical College, New Delhi, India).</p></caption><graphic xlink:href="WJCC-5-203-g012"/></fig></sec><sec><title>Vesicular PR</title><p>Generalized itchy eruption of vesicles of 2-6 mm in diameter with a rosette scaling has been described in young adults and children[<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B21" ref-type="bibr">21</xref>] (Figure <xref ref-type="fig" rid="F13">13</xref>).</p><fig id="F13" position="float"><label>Figure 13</label><caption><p>Vesicular pityriasis rosea. Vesicular lesions surrounding round to oval plaques (Courtesy of Dibyendu Basu, Junior Resident, Dermatology, Medical College and Hospital, Kolkata, West Bengal, India).</p></caption><graphic xlink:href="WJCC-5-203-g013"/></fig></sec><sec><title>Gigantea PR of darier</title><p>The dimensions of the herald patch is greater than usual, being described with the size and shape of a pear[<xref rid="B22" ref-type="bibr">22</xref>] (Figure <xref ref-type="fig" rid="F14">14</xref>).</p><fig id="F14" position="float"><label>Figure 14</label><caption><p>Giant pityriasis rosea. Large herald patch (Courtesy of Soumya Jagadeesan, Assistant Professor, Dermatology, Amrita Institute of Medical Sciences, Kochi, Kerala, India).</p></caption><graphic xlink:href="WJCC-5-203-g014"/></fig></sec><sec><title>Hypopigmented PR</title><p>It is essentially similar to the classic PR, with a preceding herald patch and a secondary eruption, but with hypopigmented lesions from the beginning, mainly distributed on the trunk (Figure <xref ref-type="fig" rid="F15">15</xref>). It is more frequent in dark-skinned individuals. It should not be confused with secondary hypopigmentation after a common PR.</p><fig id="F15" position="float"><label>Figure 15</label><caption><p>Hypopigmented pityriasis rosea. Round to oval hypopigmented lesions during the whole course of the eruption.</p></caption><graphic xlink:href="WJCC-5-203-g015"/></fig></sec><sec><title>Irritated PR</title><p>A PR with severe itch, pain and burning sensation on contact with sweat[<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B23" ref-type="bibr">23</xref>] (Figure <xref ref-type="fig" rid="F16">16</xref>).</p><fig id="F16" position="float"><label>Figure 16</label><caption><p>Irritated pityriasis rosea. Symptomatic eczematous lesions (Courtesy of Dipti Das, Consultant Dermatologist, Dr Marwah&#x02019;s Skin Clinic, Mumbai, Maharashtra, India).</p></caption><graphic xlink:href="WJCC-5-203-g016"/></fig></sec><sec><title>Relapsing PR</title><p>It usually recurs within one year of the first episode, among 2.8%-3.7% of patients[<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B24" ref-type="bibr">24</xref>]. Relapses usually show absence of herald patch, and the size and number of secondary lesions are smaller. The duration of this episode is shorter and with less constitutional symptoms. Multiple relapses - though rare - have been described[<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>].</p></sec><sec><title>Persistent PR</title><p>By definition it lasts more than 3 mo. Its incidence in a series was 2%[<xref rid="B1" ref-type="bibr">1</xref>]. Most patients (75%) show a herald patch[<xref rid="B1" ref-type="bibr">1</xref>] and complain of systemic symptoms (most commonly fatigue, or headache, insomnia, irritability). The eruption persists for 12-24 wk. Oral lesions are common (75%), principally strawberry tongue, erythematous macules, vesicular lesions and petechiae.</p></sec><sec><title>Recurrent PR</title><p>Rarely, there can be multiple episodes of PR in a lifetime[<xref rid="B25" ref-type="bibr">25</xref>-<xref rid="B27" ref-type="bibr">27</xref>].</p></sec><sec><title>Relapsing and persisting PR</title><p>It has been described in a young man with three episodes of PR within one year-fulfilling the criteria for relapsing PR, and the last episode during 7 mo-consistent with persistent PR. Noteworthy, the patient presented with multiple oral ulcers[<xref rid="B28" ref-type="bibr">28</xref>].</p></sec><sec><title>Oral involvement in PR</title><p>Oral lesions in PR are more common in dark skinned people[<xref rid="B29" ref-type="bibr">29</xref>]. The lesions are difficult to differentiate from aphthous ulcers. Its appearance should coincide with a generalized eruption with the characteristics of PR[<xref rid="B4" ref-type="bibr">4</xref>]. The lesions may be punctate, erosive, bullous or hemorrhagic. They disappear concomitantly as the skin eruption fades.</p></sec><sec><title>PR-like rashes</title><p>They consist of exanthematous rashes which appear following the intake of several drugs: ACE inhibitors[<xref rid="B30" ref-type="bibr">30</xref>-<xref rid="B32" ref-type="bibr">32</xref>], gold[<xref rid="B33" ref-type="bibr">33</xref>-<xref rid="B36" ref-type="bibr">36</xref>], isotretinoin[<xref rid="B37" ref-type="bibr">37</xref>], non-steroidal anti-inflammatory agents[<xref rid="B38" ref-type="bibr">38</xref>,<xref rid="B39" ref-type="bibr">39</xref>], omeprazole[<xref rid="B40" ref-type="bibr">40</xref>], terbinafine[<xref rid="B41" ref-type="bibr">41</xref>], and tyrosine-kinase inhibitors[<xref rid="B42" ref-type="bibr">42</xref>]. Many of them resemble PR vaguely (Figure <xref ref-type="fig" rid="F17">17</xref>), so it may be considered as a separate condition. There is no previous herald patch and the eruption is monomorphous.</p><fig id="F17" position="float"><label>Figure 17</label><caption><p>Pityriasis rosea-like rash. A: The eruption in this case was probably related to the ingestion of levothyroxine in a 33-year-old man, extensively affecting the trunk; B: The lesions are small and monomorphous (Courtesy of Dr. Elizabeth Rendic).</p></caption><graphic xlink:href="WJCC-5-203-g017"/></fig></sec></sec><sec><title>DISCUSSION</title><p>PR is a self-limited, acute inflammatory dermatosis, which occasionally could be persistent or recurrent. In rare situations, the symptoms or presentation may be troublesome, thus making difficulty in diagnosis or having a significant impact on the patient&#x02019;s quality-of-life. Its etiology has not been clearly established, but a viral origin has been suspected for years.</p><p>Recently, there are increasing evidences to suggest the role of human herpes virus (HHV) in the etiopathogenesis of PR[<xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B44" ref-type="bibr">44</xref>]. Additional evidences suggest that PR is associated with reactivation of HHV 6-7[<xref rid="B44" ref-type="bibr">44</xref>]. Diminished levels of natural killer cells and B-cell activity in the lesions of PR has been observed. This suggests the role of a T-cell mediated immunity. Besides, increased amounts of CD4 T cells and Langerhans cells have been found in the dermis, which possibly points towards viral antigen processing and presentation. However, this matter is still debated since some individuals are infected with HHV 6-7 and do not develop the disease. PR has been also reported following vaccinations as well (B<italic>acillus</italic> Calmette-Guerin, influenza, H1N1, diphtheria, smallpox, hepatitis B, pneumococcus, <italic>etc</italic>.)[<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B46" ref-type="bibr">46</xref>].</p><p>The diagnosis of PR is essentially clinical (Table <xref ref-type="table" rid="T2">2</xref>)[<xref rid="B47" ref-type="bibr">47</xref>], and in rare circumstances a biopsy may be required. Histological features are not specific and include focal parakeratosis, hypogranulosis, spongiosis, papillary dermal edema, mild perivascular lymphohistiocytic infiltrate, exocytosis and extravasated erythrocytes in the papillary dermis.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Diagnostic criteria of pityriasis rosea[<xref rid="B47" ref-type="bibr">47</xref>]</p></caption><table frame="hsides" rules="groups"><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Mandatory clinical features</td></tr><tr><td align="left" rowspan="1" colspan="1">Discrete circular or oval lesions</td></tr><tr><td align="left" rowspan="1" colspan="1">Scaling within most lesions</td></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral collarette scaling</td></tr><tr><td align="left" rowspan="1" colspan="1">Optional clinical features</td></tr><tr><td align="left" rowspan="1" colspan="1">Trunk and proximal limb distribution</td></tr><tr><td align="left" rowspan="1" colspan="1">Distribution along cutaneous cleavage lines</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous herald patch</td></tr></tbody></table></table-wrap><sec><title>Differential diagnosis[<xref rid="B48" ref-type="bibr">48</xref>]</title><p><bold>Secondary syphilis:</bold> Meticulous history taking, previous history of chancre, lymphadenopathy, positive VDRL test, histology showing plasma cells and endarteritis obliterans are suggestive. Lesions of secondary syphilis are monomorphous and always asymptomatic; they almost always affect palms and soles.</p><p><bold>Dermatophytosis:</bold> It may be troublesome to differentiate when the only lesion of PR is the herald patch. However, a mycotic lesion expands progressively and shows a clear center, whereas herald patch remains inalterable. Positive KOH mount is the pointer.</p><p><bold>Guttate psoriasis:</bold> History of sore throat, presence of rain-drop pattern and histology are important clues. Scales are thicker and silvery-white.</p><p><bold>Subacute cutaneous lupus erythematosus:</bold> Photosensitivity is the rule. Besides, histology shows epidermal atrophy and basal layer degeneration.</p><p>Rarely, primary HIV infection, seborrhoeic dermatitis, drug rash, erythema multiforme and cutaneous T cell lymphoma may also be confused with PR. Hypopigmented variant may be confused with pityriasis alba (lesions are mainly located on the face or arms and it is usually associated with atopic dermatitis), hypopigmented mycosis fungoides (lesions are large, persistent, and mainly distributed on buttocks and lower trunk), and progressive macular hypomelanosis of the trunk (lesions are slowly progressive, tend to coalesce, and do not show desquamation).</p></sec><sec><title>Therapeutic options</title><p>Many cases require no treatment at all, only reassurance directed to the patients, underlying the benign nature and self-limited duration of the disease, which do not leave sequelae and that other members of their family or friends will be not affected. Therapeutic options when needed (in the case of many or symptomatic lesions) include the use of emollients and topical corticosteroids, and antihistamines when itching.</p><p>The use of oral macrolides (erythromycin and azithromycin) have shown controversial results[<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B50" ref-type="bibr">50</xref>]. Initially, these were found to be beneficial but recent studies show that macrolides are ineffective in the management of PR.</p><p>Since the current concepts of etiopathogenesis may imply the role of HHV-7 and HHV-6 in the causation of PR, antivirals like acyclovir have been found to show good response[<xref rid="B51" ref-type="bibr">51</xref>-<xref rid="B54" ref-type="bibr">54</xref>]. The effectiveness of phototherapy is debated and further studies need to be conducted[<xref rid="B55" ref-type="bibr">55</xref>,<xref rid="B56" ref-type="bibr">56</xref>]. A statement about the management of PR has been recently raised[<xref rid="B57" ref-type="bibr">57</xref>]. Main conclusions include an adequate diagnosis, impact of the eruption in the quality of life since many patients do not necessitate any treatment, and use of oral acyclovir 400 mg three times daily for seven days, when not contraindicated or possible adverse effects are suspected.</p></sec></sec><sec><title>CONCLUSION</title><p>The diagnosis of typical PR should not be difficult for any dermatologist. Nevertheless, its atypical presentations - as defined here - can be a challenge for the clinician. We hope the article will be helpful to the clinicians, in identifying numerous variants of this common disease.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>Conflict-of-interest statement: Authors declare no conflict of interests for this article.</p></fn><fn><p>Manuscript source: Invited manuscript</p></fn><fn><p>Specialty type: Medicine, research and experimental</p></fn><fn><p>Country of origin: Chile</p></fn><fn><p>Peer-review report classification</p></fn><fn><p>Grade A (Excellent): 0</p></fn><fn><p>Grade B (Very good): B</p></fn><fn><p>Grade C (Good): C, C</p></fn><fn><p>Grade D (Fair): D</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn><p>Peer-review started: February 9, 2017</p></fn><fn><p>First decision: March 7, 2017</p></fn><fn><p>Article in press: April 19, 2017</p></fn><fn><p>P- Reviewer: Firooz A, Hu SCS, Sadighha A, Vasconcellos C S- Editor: Ji FF L- Editor: A E- Editor: Wu HL</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Broccolo</surname><given-names>F</given-names></name><name><surname>Ciccarese</surname><given-names>G</given-names></name><name><surname>Rebora</surname><given-names>A</given-names></name><name><surname>Parodi</surname><given-names>A</given-names></name></person-group><article-title>Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection</article-title><source>Dermatology</source><year>2015</year><volume>230</volume><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">25612842</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Souza Sittart</surname><given-names>JA</given-names></name><name><surname>Tayah</surname><given-names>M</given-names></name><name><surname>Soares</surname><given-names>Z</given-names></name></person-group><article-title>Incidence pityriasis rosea of Gibert in the Dermatology Service of the Hospital do Servidor P&#x000fa;blico in the state of S&#x000e3;o Paulo</article-title><source>Med Cutan Ibero Lat Am</source><year>1984</year><volume>12</volume><fpage>336</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">6392788</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olumide</surname><given-names>Y</given-names></name></person-group><article-title>Pityriasis rosea in Lagos</article-title><source>Int J Dermatol</source><year>1987</year><volume>26</volume><fpage>234</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">3596885</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuh</surname><given-names>A</given-names></name><name><surname>Zawar</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name></person-group><article-title>Atypical presentations of pityriasis rosea: case presentations</article-title><source>J Eur Acad Dermatol Venereol</source><year>2005</year><volume>19</volume><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">15649208</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>LM</given-names></name><name><surname>Allen</surname><given-names>R</given-names></name><name><surname>Janniger</surname><given-names>CK</given-names></name><name><surname>Schwartz</surname><given-names>RA</given-names></name></person-group><article-title>Pityriasis rosea: an important papulosquamous disorder</article-title><source>Int J Dermatol</source><year>2005</year><volume>44</volume><fpage>757</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">16135147</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>TY</given-names></name><name><surname>Ilstrup</surname><given-names>DM</given-names></name><name><surname>Perry</surname><given-names>HO</given-names></name><name><surname>Kurland</surname><given-names>LT</given-names></name></person-group><article-title>Pityriasis rosea in Rochester, Minnesota, 1969 to 1978</article-title><source>J Am Acad Dermatol</source><year>1982</year><volume>7</volume><fpage>80</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">6980904</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Ciccarese</surname><given-names>G</given-names></name><name><surname>Broccolo</surname><given-names>F</given-names></name><name><surname>Cozzani</surname><given-names>E</given-names></name><name><surname>Parodi</surname><given-names>A</given-names></name></person-group><article-title>Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations</article-title><source>Dermatology</source><year>2015</year><volume>231</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">25997658</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Ciccarese</surname><given-names>G</given-names></name><name><surname>Rebora</surname><given-names>A</given-names></name><name><surname>Broccolo</surname><given-names>F</given-names></name><name><surname>Parodi</surname><given-names>A</given-names></name></person-group><article-title>Pityriasis Rosea: A Comprehensive Classification</article-title><source>Dermatology</source><year>2016</year><volume>232</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">27096928</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacyk</surname><given-names>WK</given-names></name></person-group><article-title>Pityriasis rosea in Nigerians</article-title><source>Int J Dermatol</source><year>1980</year><volume>19</volume><fpage>397</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">7419321</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klauder</surname><given-names>JV</given-names></name></person-group><article-title>Pityriasis rosea with particular reference to its unusual manifestations</article-title><source>JAMA</source><year>1924</year><volume>82</volume><fpage>178</fpage><lpage>83</lpage></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkany</surname><given-names>I</given-names></name><name><surname>Hare</surname><given-names>PJ</given-names></name></person-group><article-title>Pityriasis rotunda. (pityriasis circinata)</article-title><source>Br J Dermatol</source><year>1964</year><volume>76</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">14155119</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibney</surname><given-names>MD</given-names></name><name><surname>Leonardi</surname><given-names>CL</given-names></name></person-group><article-title>Acute papulosquamous eruption of the extremities demonstrating an isomorphic response. Inverse pityriasis rosea (PR)</article-title><source>Arch Dermatol</source><year>1997</year><volume>133</volume><fpage>651, 654</fpage><pub-id pub-id-type="pmid">9158423</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zawar</surname><given-names>V</given-names></name></person-group><article-title>Acral pityriasis rosea in an infant with palmoplantar lesions: A novel manifestation</article-title><source>Indian Dermatol Online J</source><year>2010</year><volume>1</volume><fpage>21</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">23130187</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Sarkar</surname><given-names>TK</given-names></name><name><surname>Chandra</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Gharami</surname><given-names>RC</given-names></name></person-group><article-title>A case series of erythema multiforme-like pityriasis rosea</article-title><source>Indian Dermatol Online J</source><year>2016</year><volume>7</volume><fpage>212</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">27294066</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relhan</surname><given-names>V</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Garg</surname><given-names>VK</given-names></name><name><surname>Khurana</surname><given-names>N</given-names></name></person-group><article-title>Pityriasis rosea with erythema multiforme - like lesions: an observational analysis</article-title><source>Indian J Dermatol</source><year>2013</year><volume>58</volume><fpage>242</fpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zawar</surname><given-names>V</given-names></name><name><surname>Chuh</surname><given-names>A</given-names></name></person-group><article-title>Follicular pityriasis rosea. A case report and a new classification of clinical variants of the disease</article-title><source>J Dermatol Case Rep</source><year>2012</year><volume>6</volume><fpage>36</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">22826716</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>CR</given-names></name></person-group><article-title>Dapsone treatment in a case of vesicular pityriasis rosea</article-title><source>Lancet</source><year>1971</year><volume>2</volume><fpage>493</fpage></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>RL</given-names></name></person-group><article-title>Letter: Vesicular pityriasis rosea</article-title><source>Arch Dermatol</source><year>1976</year><volume>112</volume><fpage>410</fpage><pub-id pub-id-type="pmid">1259454</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>A</given-names></name></person-group><article-title>Vesicular pityriasis rosea</article-title><source>Arch Dermatol</source><year>1977</year><volume>113</volume><fpage>1733</fpage><lpage>1734</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>SJ</given-names></name></person-group><article-title>Pityriasis rosea with erythema multiforme-like lesions</article-title><source>J Am Acad Dermatol</source><year>1987</year><volume>17</volume><fpage>135</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">3611442</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bari</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>BA</given-names></name></person-group><article-title>Purpuric vesicular eruption in a 7-year-old girl. Vesicular pityriasis rosea</article-title><source>Arch Dermatol</source><year>1990</year><volume>126</volume><fpage>1497, 1500</fpage><lpage>1501</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pringle</surname><given-names>JJ</given-names></name></person-group><article-title>Case presentation, section on dermatology, Royal Society of Medicine</article-title><source>Br J Dermatol</source><year>1915</year><volume>27</volume><fpage>309</fpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eslick</surname><given-names>GD</given-names></name></person-group><article-title>Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis</article-title><source>Int J Dermatol</source><year>2002</year><volume>41</volume><fpage>788</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">12453007</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjornberg</surname><given-names>A</given-names></name><name><surname>Hellgren</surname><given-names>L</given-names></name></person-group><article-title>Pityriasis rosea. A statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls</article-title><source>Acta Derm Venereol Suppl (Stockh)</source><year>1962</year><volume>42</volume><issue>Suppl 50</issue><fpage>1</fpage><lpage>68</lpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halkier-S&#x000f8;rensen</surname><given-names>L</given-names></name></person-group><article-title>Recurrent pityriasis rosea. New episodes every year for five years. A case report</article-title><source>Acta Derm Venereol</source><year>1990</year><volume>70</volume><fpage>179</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">1969211</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zawar</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><article-title>Multiple recurrences of pityriasis rosea of Vidal: a novel presentation</article-title><source>Clin Exp Dermatol</source><year>2009</year><volume>34</volume><fpage>e114</fpage><lpage>e116</lpage><pub-id pub-id-type="pmid">19508465</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Pandey</surname><given-names>SS</given-names></name></person-group><article-title>Recurrent pityriasis rosea</article-title><source>Indian J Dermatol Venereol Leprol</source><year>1998</year><volume>64</volume><fpage>237</fpage><pub-id pub-id-type="pmid">20921779</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuah</surname><given-names>SY</given-names></name><name><surname>Chia</surname><given-names>HY</given-names></name><name><surname>Tan</surname><given-names>HH</given-names></name></person-group><article-title>Recurrent and persistent pityriasis rosea: an atypical case presentation</article-title><source>Singapore Med J</source><year>2014</year><volume>55</volume><fpage>e4</fpage><lpage>e6</lpage><pub-id pub-id-type="pmid">24452984</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Broccolo</surname><given-names>F</given-names></name><name><surname>Rebora</surname><given-names>A</given-names></name></person-group><article-title>Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology</article-title><source>J Am Acad Dermatol</source><year>2009</year><volume>61</volume><fpage>303</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">19615540</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkin</surname><given-names>JK</given-names></name><name><surname>Kirkendall</surname><given-names>WM</given-names></name></person-group><article-title>Pityriasis rosea-like rash from captopril</article-title><source>Arch Dermatol</source><year>1982</year><volume>118</volume><fpage>186</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">7039511</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotstein</surname><given-names>E</given-names></name><name><surname>Rotstein</surname><given-names>H</given-names></name></person-group><article-title>Drug eruptions with lichenoid histology produced by captopril</article-title><source>Australas J Dermatol</source><year>1989</year><volume>30</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">2535012</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghersetich</surname><given-names>I</given-names></name><name><surname>Rindi</surname><given-names>L</given-names></name><name><surname>Teofoli</surname><given-names>P</given-names></name><name><surname>Tsampau</surname><given-names>D</given-names></name><name><surname>Palleschi</surname><given-names>GM</given-names></name><name><surname>Lotti</surname><given-names>T</given-names></name></person-group><article-title>[Pityriasis rosea-like skin eruptions caused by captopril]</article-title><source>G Ital Dermatol Venereol</source><year>1990</year><volume>125</volume><fpage>457</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">2150508</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>C</given-names></name><name><surname>Burg</surname><given-names>G</given-names></name><name><surname>Jung</surname><given-names>C</given-names></name></person-group><article-title>Cutaneous side effects of gold therapy. Clinical and histologic results</article-title><source>Z Rheumatol</source><year>1986</year><volume>45</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">2944308</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>AG</given-names></name><name><surname>Davis</surname><given-names>MJ</given-names></name><name><surname>Mattey</surname><given-names>D</given-names></name><name><surname>Dawes</surname><given-names>PT</given-names></name></person-group><article-title>Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold</article-title><source>Ann Rheum Dis</source><year>1992</year><volume>51</volume><fpage>881</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">1385941</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizeaux-Parneix</surname><given-names>V</given-names></name><name><surname>Bedane</surname><given-names>C</given-names></name><name><surname>Lavignac</surname><given-names>C</given-names></name><name><surname>Bernard</surname><given-names>P</given-names></name><name><surname>Bonnetblanc</surname><given-names>JM</given-names></name></person-group><article-title>Cutaneous reactions to gold salts</article-title><source>Ann Dermatol Venereol</source><year>1994</year><volume>121</volume><fpage>793</fpage><lpage>797</lpage><pub-id pub-id-type="pmid">7631987</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnetblanc</surname><given-names>JM</given-names></name></person-group><article-title>Cutaneous reactions to gold salts</article-title><source>Presse Med</source><year>1996</year><volume>25</volume><fpage>1555</fpage><lpage>1558</lpage><pub-id pub-id-type="pmid">8952665</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfman</surname><given-names>RJ</given-names></name><name><surname>Brickman</surname><given-names>M</given-names></name><name><surname>Fahey</surname><given-names>J</given-names></name></person-group><article-title>Isotretinoin dermatitis simulating acute pityriasis rosea</article-title><source>Cutis</source><year>1984</year><volume>33</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">6233097</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corke</surname><given-names>CF</given-names></name><name><surname>Meyrick</surname><given-names>TR</given-names></name><name><surname>Huskisson</surname><given-names>EC</given-names></name><name><surname>Kirby</surname><given-names>JD</given-names></name></person-group><article-title>Pityriasis rosea-like rashes complicating drug therapy for rheumatoid arthritis</article-title><source>Br J Rheumatol</source><year>1983</year><volume>22</volume><fpage>187</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">6871589</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yosipovitch</surname><given-names>G</given-names></name><name><surname>Kuperman</surname><given-names>O</given-names></name><name><surname>Livni</surname><given-names>E</given-names></name><name><surname>Avinoach</surname><given-names>I</given-names></name><name><surname>Halevy</surname><given-names>S</given-names></name></person-group><article-title>Pityriasis rosea-like eruption after anti-inflammatory and antipyretic medication</article-title><source>Harefuah</source><year>1993</year><volume>124</volume><fpage>198</fpage><lpage>200, 247</lpage><pub-id pub-id-type="pmid">8495898</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>C</given-names></name></person-group><article-title>Pityriasis rosea-like eruption in a patient receiving omeprazole</article-title><source>Br J Dermatol</source><year>1996</year><volume>135</volume><fpage>660</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">8915176</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>AK</given-names></name><name><surname>Lynde</surname><given-names>CW</given-names></name><name><surname>Lauzon</surname><given-names>GJ</given-names></name><name><surname>Mehlmauer</surname><given-names>MA</given-names></name><name><surname>Braddock</surname><given-names>SW</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Del Rosso</surname><given-names>JQ</given-names></name><name><surname>Shear</surname><given-names>NH</given-names></name></person-group><article-title>Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature</article-title><source>Br J Dermatol</source><year>1998</year><volume>138</volume><fpage>529</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">9580815</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantopoulos</surname><given-names>K</given-names></name><name><surname>Papadogianni</surname><given-names>A</given-names></name><name><surname>Dimopoulou</surname><given-names>M</given-names></name><name><surname>Kourelis</surname><given-names>C</given-names></name><name><surname>Meletis</surname><given-names>J</given-names></name></person-group><article-title>Pityriasis rosea associated with imatinib (STI571, Gleevec)</article-title><source>Dermatology</source><year>2002</year><volume>205</volume><fpage>172</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">12218236</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Malaguti</surname><given-names>F</given-names></name><name><surname>Ranieri</surname><given-names>E</given-names></name><name><surname>Losi</surname><given-names>E</given-names></name><name><surname>Rebora</surname><given-names>A</given-names></name></person-group><article-title>Human herpes virus-like particles in pityriasis rosea lesions: an electron microscopy study</article-title><source>J Cutan Pathol</source><year>2002</year><volume>29</volume><fpage>359</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">12135467</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broccolo</surname><given-names>F</given-names></name><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Careddu</surname><given-names>AM</given-names></name><name><surname>Foglieni</surname><given-names>C</given-names></name><name><surname>Turbino</surname><given-names>L</given-names></name><name><surname>Cocuzza</surname><given-names>CE</given-names></name><name><surname>Gelmetti</surname><given-names>C</given-names></name><name><surname>Lusso</surname><given-names>P</given-names></name><name><surname>Rebora</surname><given-names>AE</given-names></name><name><surname>Malnati</surname><given-names>MS</given-names></name></person-group><article-title>Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7</article-title><source>J Invest Dermatol</source><year>2005</year><volume>124</volume><fpage>1234</fpage><lpage>1240</lpage><pub-id pub-id-type="pmid">15955099</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>CW</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>CY</given-names></name></person-group><article-title>Pityriasis rosea-like rash secondary to intravesical bacillus calmette-guerin immunotherapy</article-title><source>Ann Dermatol</source><year>2012</year><volume>24</volume><fpage>360</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">22879725</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papakostas</surname><given-names>D</given-names></name><name><surname>Stavropoulos</surname><given-names>PG</given-names></name><name><surname>Papafragkaki</surname><given-names>D</given-names></name><name><surname>Grigoraki</surname><given-names>E</given-names></name><name><surname>Avgerinou</surname><given-names>G</given-names></name><name><surname>Antoniou</surname><given-names>C</given-names></name></person-group><article-title>An atypical case of pityriasis rosea gigantea after influenza vaccination</article-title><source>Case Rep Dermatol</source><year>2014</year><volume>6</volume><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">24847250</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuh</surname><given-names>AA</given-names></name></person-group><article-title>Diagnostic criteria for pityriasis rosea: a prospective case control study for assessment of validity</article-title><source>J Eur Acad Dermatol Venereol</source><year>2003</year><volume>17</volume><fpage>101</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">12602987</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>K</given-names></name><name><surname>Relhan</surname><given-names>V</given-names></name><name><surname>Relhan</surname><given-names>AK</given-names></name><name><surname>Garg</surname><given-names>VK</given-names></name></person-group><article-title>Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects</article-title><source>Indian J Dermatol</source><year>2016</year><volume>61</volume><fpage>375</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">27512182</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bukhari</surname><given-names>IA</given-names></name></person-group><article-title>Oral erythromycin is ineffective in the treatment of pityriasis rosea</article-title><source>J Drugs Dermatol</source><year>2008</year><volume>7</volume><fpage>625</fpage><pub-id pub-id-type="pmid">18664152</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandhi</surname><given-names>D</given-names></name><name><surname>Singal</surname><given-names>A</given-names></name><name><surname>Verma</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name></person-group><article-title>The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial</article-title><source>Indian J Dermatol Venereol Leprol</source><year>2014</year><volume>80</volume><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">24448121</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drago</surname><given-names>F</given-names></name><name><surname>Vecchio</surname><given-names>F</given-names></name><name><surname>Rebora</surname><given-names>A</given-names></name></person-group><article-title>Use of high-dose acyclovir in pityriasis rosea</article-title><source>J Am Acad Dermatol</source><year>2006</year><volume>54</volume><fpage>82</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">16384760</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassai</surname><given-names>S</given-names></name><name><surname>Feily</surname><given-names>A</given-names></name><name><surname>Sina</surname><given-names>N</given-names></name><name><surname>Abtahian</surname><given-names>S</given-names></name></person-group><article-title>Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients</article-title><source>J Eur Acad Dermatol Venereol</source><year>2011</year><volume>25</volume><fpage>24</fpage><lpage>26</lpage></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>S</given-names></name></person-group><article-title>A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea</article-title><source>J Clin Diagn Res</source><year>2014</year><volume>8</volume><fpage>YC01</fpage><lpage>YC04</lpage></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Sil</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>NK</given-names></name><name><surname>Roy</surname><given-names>K</given-names></name><name><surname>Das</surname><given-names>AK</given-names></name><name><surname>Bandyopadhyay</surname><given-names>D</given-names></name></person-group><article-title>Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability</article-title><source>Indian Dermatol Online J</source><year>2015</year><volume>6</volume><fpage>181</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">26009712</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castanedo-Cazares</surname><given-names>JP</given-names></name><name><surname>Lepe</surname><given-names>V</given-names></name><name><surname>Moncada</surname><given-names>B</given-names></name></person-group><article-title>Should we still use phototherapy for Pityriasis rosea?</article-title><source>Photodermatol Photoimmunol Photomed</source><year>2003</year><volume>19</volume><fpage>160</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">12914603</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Oh</surname><given-names>BH</given-names></name><name><surname>Ko</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>YW</given-names></name><name><surname>Choe</surname><given-names>YB</given-names></name><name><surname>Ahn</surname><given-names>KJ</given-names></name></person-group><article-title>Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea</article-title><source>Ann Dermatol</source><year>2009</year><volume>21</volume><fpage>230</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">20523795</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuh</surname><given-names>A</given-names></name><name><surname>Zawar</surname><given-names>V</given-names></name><name><surname>Sciallis</surname><given-names>G</given-names></name><name><surname>Kempf</surname><given-names>W</given-names></name></person-group><article-title>A position statement on the management of patients with pityriasis rosea</article-title><source>J Eur Acad Dermatol Venereol</source><year>2016</year><volume>30</volume><fpage>1670</fpage><lpage>1681</lpage><pub-id pub-id-type="pmid">27406919</pub-id></element-citation></ref></ref-list></back></article>